ALLERGAN INC
4, 1996-07-09
PHARMACEUTICAL PREPARATIONS
Previous: ADVANCED ENVIRONMENTAL RECYCLING TECHNOLOGIES INC, 8-K, 1996-07-09
Next: ALLERGAN INC, 4, 1996-07-09



U.S. SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C.
FORM 4
ANNUAL STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP
( ) Check box if no longer subject to Section 16. 
Form 4 or Form 5 obligations may continue. See Instructions 1(b).
1. Name and Address of Reporting Person
   Tunney, Francis R., Jr.
   Allergan, Inc.
   2525 Dupont Drive
   Irvine, CA  92612
   U.S.A.
2. Issuer Name and Ticker or Trading Symbol
   Allergan, Inc.
   AGN
3. IRS or Social Security Number of Reporting Person (Voluntary)
   
4. Statement for Month/Year
   June 1996
5. If Amendment, Date of Original (Month/Year)
   
6. Relationship of Reporting Person to Issuer (Check all applicable)
   ( ) Director ( ) 10% Owner (X) Officer (give title below) ( ) Other 
   (specify below)
   Corporate Vice President, General Counsel and Secretary
<TABLE>
<CAPTION>
___________________________________________________________________________________________________________________________________
 Table I -- Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned                                                 |
___________________________________________________________________________________________________________________________________|
1. Title of Security       |2.    |3.    |4.Securities Acquired (A)         |5.Amount of        |6.Dir |7.Nature of Indirect       |
                           | Transaction |  or Disposed of (D)              |  Securities       |ect   |  Beneficial Ownership     |
                           |      |      |                                  |  Beneficially     |(D)or |                           |
                           |      |    | |                  | A/|           |  Owned at         |Indir |                           |
                           | Date |Code|V|    Amount        | D |    Price  |  End of Year      |ect(I)|                           |
___________________________________________________________________________________________________________________________________|
<S>                        <C>    <C>  <C><C>               <C> <C>         <C>                 <C>    <C>
Common Stock               |6/5/96|J(1)| |2,452             |A  |$20.00     |                   |D     |                           |
- -----------------------------------------------------------------------------------------------------------------------------------|
Common Stock               |6/5/96|S   | |2,452             |D  |$38.50     |3,400              |D     |                           |
- -----------------------------------------------------------------------------------------------------------------------------------|
Common Stock               |      |    | |                  |   |           |3,687              |I     |By Trust (2)               |
- -----------------------------------------------------------------------------------------------------------------------------------|
Common Stock               |      |    | |                  |   |           |1,000              |I     |By Spouse                  |
- -----------------------------------------------------------------------------------------------------------------------------------|
___________________________________________________________________________________________________________________________________|
<CAPTION>
___________________________________________________________________________________________________________________________________
 Table II -- Derivative Securitites Acquired, Disposed of, or Beneficially Owned                                                   |
___________________________________________________________________________________________________________________________________|
1.Title of Derivative |2.Con-  |3.   |4.    |5.Number of De |6.Date Exer|7.Title and Amount  |8.Price|9.Number    |10.|11.Nature of|
  Security            |version |Transaction | rivative Secu |cisable and|  of Underlying     |of Deri|of Deriva   |Dir|Indirect    |
                      |or Exer |     |      | rities Acqui  |Expiration |  Securities        |vative |tive        |ect|Beneficial  |
                      |cise    |     |      | red(A) or Dis |Date(Month/|                    |Secu   |Securities  |(D)|Ownership   |
                      |Price of|     |      | posed of(D)   |Day/Year)  |                    |rity   |Benefi      |or |            |
                      |Deriva- |     |      |               |Date |Expir|                    |       |ficially    |Ind|            |
                      |tive    |     |      |           | A/|Exer-|ation|   Title and Number |       |Owned at    |ire|            |
                      |Secu-   |     |    | |           | D |cisa-|Date |   of Shares        |       |End of      |ct |            |
                      |rity    |Date |Code|V|  Amount   |   |ble  |     |                    |       |Year        |(I)|            |
___________________________________________________________________________________________________________________________________|
<S>                   <C>      <C>   <C>  <C><C>        <C> <C>   <C>   <C>          <C>     <C>     <C>          <C> <C>
Employee Stock Option |$35.125 |4/22/|J(3)|V|20,000     |A  |(3)  |4/22/|Common Stock|20,000 |       |            |D  |            |
(right to buy) with ta|        |96   |    | |           |   |     |06   |            |       |       |            |   |            |
ndem tax withholding r|        |     |    | |           |   |     |     |            |       |       |            |   |            |
ight                  |        |     |    | |           |   |     |     |            |       |       |            |   |            |
- -----------------------------------------------------------------------------------------------------------------------------------|
Employee Stock Option |$20.00  |6/5/9|J(1)| |2,452      |D  |(4)  |6/24/|Common Stock|2,452  |       |138,434     |D  |            |
(right to buy) with ta|        |6    |    | |           |   |     |96   |            |       |       |            |   |            |
ndem tax withholding r|        |     |    | |           |   |     |     |            |       |       |            |   |            |
ight                  |        |     |    | |           |   |     |     |            |       |       |            |   |            |
- -----------------------------------------------------------------------------------------------------------------------------------|
                      |        |     |    | |           |   |     |     |            |       |       |            |   |            |
___________________________________________________________________________________________________________________________________|
</TABLE>
Explanation of Responses:
(1)  Exercise of in-the-money derivative security pursuant to an old Rule 16b-3 
Plan.  Column 9 represents all stock options outstanding as of 6/30/96.
(2)  The shares indirectly owned at end of month are held by a revocable family 
trust established by reporting person as co-settlor for benefit of self
       and 
others.
(3)  Granted pursuant to the Allergan, Inc. 1989 Incentive Compensation Plan, 
which complies with old Rule 16b-3; the option becomes exercisable in 
      25% increments on 4/22/97, 4/22/98, 4/22/99, and 
4/22/00.
(4)  Granted pursuant to the Allergan, Inc. 1989 Incentive Compensation Plan, 
which complies with old Rule 16b-3; the option became exercisable in
      25% increments on 6/24/87, 6/24/88, 6/24/89, and 
6/24/90.
SIGNATURE OF REPORTING PERSON
/s/ Francis R. Tunney, Jr.
DATE
7/5/96



© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission